Login / Signup

Prophylactic medication for the prevention of endoscopic recurrence in Crohn's disease: a prospective study based on clinical risk stratification.

Jeanine H C ArkenboschEvelien M J BeelenGerard DijkstraMariëlle Romberg-CampsMarjolijn DuijvesteinFrank HoentjenSander van der MarelP W Jeroen MaljaarsSita JansenNanne K H de BoerRachel L WestCarmen S HorjusLaurents P S StassenFiona D M van SchaikOddeke van RulerBindia J H JharapMarijn VisschedijkAlfred JanssenNicole S ErlerMichael DoukasAriadne H A G OomsGursah Kats-UgurluC Janneke van der WoudeAnnemarie C de Vriesnull null
Published in: Journal of Crohn's & colitis (2022)
Adherence to this management algorithm is 65%. Prophylactic medication after ICR prevents endoscopic recurrence in low and high-risk patients. Clinical risk stratification has an acceptable predictive value, but further refinement is needed.
Keyphrases